Application 203312
- Type
- NDA
- Sponsor
- IMPAX LABS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | RYTARY | CARBIDOPA; LEVODOPA | CAPSULE, EXTENDED RELEASE;ORAL | 23.75MG;95MG | Yes | No |
| 002 | RYTARY | CARBIDOPA; LEVODOPA | CAPSULE, EXTENDED RELEASE;ORAL | 36.25MG;145MG | Yes | No |
| 003 | RYTARY | CARBIDOPA; LEVODOPA | CAPSULE, EXTENDED RELEASE;ORAL | 48.75MG;195MG | Yes | No |
| 004 | RYTARY | CARBIDOPA; LEVODOPA | CAPSULE, EXTENDED RELEASE;ORAL | 61.25MG;245MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N203312-001 | RYTARY | CARBIDOPA; LEVODOPA | 23.75MG;95MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 2015-01-07 |
| N203312-002 | RYTARY | CARBIDOPA; LEVODOPA | 36.25MG;145MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 2015-01-07 |
| N203312-003 | RYTARY | CARBIDOPA; LEVODOPA | 48.75MG;195MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 2015-01-07 |
| N203312-004 | RYTARY | CARBIDOPA; LEVODOPA | 61.25MG;245MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2015-01-07 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N203312-001 | AB |
| N203312-002 | AB |
| N203312-003 | AB |
| N203312-004 | AB |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N203312-001 | 8377474 | 2028-12-26 | U-1645 | Drug product | 2015-01-27 |
| N203312-001 | 8377474 | 2028-12-26 | U-219 | Drug product | 2015-01-27 |
| N203312-001 | 8454998 | 2028-12-26 | U-1645 | Drug product | 2015-01-27 |
| N203312-001 | 8454998 | 2028-12-26 | U-1646 | Drug product | 2015-01-27 |
| N203312-001 | 8454998 | 2028-12-26 | U-1647 | Drug product | 2015-01-27 |
| N203312-001 | 8454998 | 2028-12-26 | U-1649 | Drug product | 2015-01-27 |
| N203312-001 | 8454998 | 2028-12-26 | U-219 | Drug product | 2015-01-27 |
| N203312-001 | 8557283 | 2028-12-26 | U-1645 | Drug product | 2015-01-27 |
| N203312-001 | 8557283 | 2028-12-26 | U-219 | Drug product | 2015-01-27 |
| N203312-001 | 9089607 | 2028-12-26 | U-1645 | Drug product | 2015-08-10 |
| N203312-001 | 9089607 | 2028-12-26 | U-1720 | Drug product | 2015-08-10 |
| N203312-001 | 9089608 | 2028-12-26 | Drug product | 2015-08-10 | |
| N203312-001 | 9463246 | 2028-12-26 | U-219 | Drug product | 2016-10-12 |
| N203312-001 | 9533046 | 2028-12-26 | U-219 | Drug product | 2017-01-11 |
| N203312-001 | 9901640 | 2028-12-26 | U-219 | Drug product | 2018-02-28 |
| N203312-002 | 8377474 | 2028-12-26 | U-1645 | Drug product | 2015-01-27 |
| N203312-002 | 8377474 | 2028-12-26 | U-219 | Drug product | 2015-01-27 |
| N203312-002 | 8454998 | 2028-12-26 | U-1645 | Drug product | 2015-01-27 |
| N203312-002 | 8454998 | 2028-12-26 | U-1646 | Drug product | 2015-01-27 |
| N203312-002 | 8454998 | 2028-12-26 | U-1647 | Drug product | 2015-01-27 |
| N203312-002 | 8454998 | 2028-12-26 | U-1649 | Drug product | 2015-01-27 |
| N203312-002 | 8454998 | 2028-12-26 | U-219 | Drug product | 2015-01-27 |
| N203312-002 | 8557283 | 2028-12-26 | U-1645 | Drug product | 2015-01-27 |
| N203312-002 | 8557283 | 2028-12-26 | U-219 | Drug product | 2015-01-27 |
| N203312-002 | 9089607 | 2028-12-26 | U-1645 | Drug product | 2015-08-10 |
| N203312-002 | 9089607 | 2028-12-26 | U-1720 | Drug product | 2015-08-10 |
| N203312-002 | 9089608 | 2028-12-26 | Drug product | 2015-08-10 | |
| N203312-002 | 9463246 | 2028-12-26 | U-219 | Drug product | 2016-10-12 |
| N203312-002 | 9533046 | 2028-12-26 | U-219 | Drug product | 2017-01-11 |
| N203312-002 | 9901640 | 2028-12-26 | U-219 | Drug product | 2018-02-28 |
| N203312-003 | 8377474 | 2028-12-26 | U-1645 | Drug product | 2015-01-27 |
| N203312-003 | 8377474 | 2028-12-26 | U-219 | Drug product | 2015-01-27 |
| N203312-003 | 8454998 | 2028-12-26 | U-1645 | Drug product | 2015-01-27 |
| N203312-003 | 8454998 | 2028-12-26 | U-1646 | Drug product | 2015-01-27 |
| N203312-003 | 8454998 | 2028-12-26 | U-1647 | Drug product | 2015-01-27 |
| N203312-003 | 8454998 | 2028-12-26 | U-1649 | Drug product | 2015-01-27 |
| N203312-003 | 8454998 | 2028-12-26 | U-219 | Drug product | 2015-01-27 |
| N203312-003 | 8557283 | 2028-12-26 | U-1645 | Drug product | 2015-01-27 |
| N203312-003 | 8557283 | 2028-12-26 | U-219 | Drug product | 2015-01-27 |
| N203312-003 | 9089607 | 2028-12-26 | U-1645 | Drug product | 2015-08-10 |
| N203312-003 | 9089607 | 2028-12-26 | U-1720 | Drug product | 2015-08-10 |
| N203312-003 | 9089608 | 2028-12-26 | Drug product | 2015-08-10 | |
| N203312-003 | 9463246 | 2028-12-26 | U-219 | Drug product | 2016-10-12 |
| N203312-003 | 9533046 | 2028-12-26 | U-219 | Drug product | 2017-01-11 |
| N203312-003 | 9901640 | 2028-12-26 | U-219 | Drug product | 2018-02-28 |
| N203312-004 | 8377474 | 2028-12-26 | U-1645 | Drug product | 2015-01-27 |
| N203312-004 | 8377474 | 2028-12-26 | U-219 | Drug product | 2015-01-27 |
| N203312-004 | 8454998 | 2028-12-26 | U-1645 | Drug product | 2015-01-27 |
| N203312-004 | 8454998 | 2028-12-26 | U-1646 | Drug product | 2015-01-27 |
| N203312-004 | 8454998 | 2028-12-26 | U-1647 | Drug product | 2015-01-27 |
| N203312-004 | 8454998 | 2028-12-26 | U-1649 | Drug product | 2015-01-27 |
| N203312-004 | 8454998 | 2028-12-26 | U-219 | Drug product | 2015-01-27 |
| N203312-004 | 8557283 | 2028-12-26 | U-1645 | Drug product | 2015-01-27 |
| N203312-004 | 8557283 | 2028-12-26 | U-219 | Drug product | 2015-01-27 |
| N203312-004 | 9089607 | 2028-12-26 | U-1645 | Drug product | 2015-08-10 |
| N203312-004 | 9089607 | 2028-12-26 | U-1720 | Drug product | 2015-08-10 |
| N203312-004 | 9089608 | 2028-12-26 | Drug product | 2015-08-10 | |
| N203312-004 | 9463246 | 2028-12-26 | U-219 | Drug product | 2016-10-12 |
| N203312-004 | 9533046 | 2028-12-26 | U-219 | Drug product | 2017-01-11 |
| N203312-004 | 9901640 | 2028-12-26 | U-219 | Drug product | 2018-02-28 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-04-04 05:41 UTC | 2022-04 | N203312-001 | RYTARY | 23.75MG;95MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2015-01-07 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N203312-002 | RYTARY | 36.25MG;145MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2015-01-07 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N203312-003 | RYTARY | 48.75MG;195MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2015-01-07 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N203312-004 | RYTARY | 61.25MG;245MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2015-01-07 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N203312-001 | RYTARY | 23.75MG;95MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2015-01-07 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N203312-002 | RYTARY | 36.25MG;145MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2015-01-07 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N203312-003 | RYTARY | 48.75MG;195MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2015-01-07 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N203312-004 | RYTARY | 61.25MG;245MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2015-01-07 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N203312-001 | RYTARY | 23.75MG;95MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2015-01-07 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N203312-002 | RYTARY | 36.25MG;145MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2015-01-07 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N203312-003 | RYTARY | 48.75MG;195MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2015-01-07 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N203312-004 | RYTARY | 61.25MG;245MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2015-01-07 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N203312-001 | RYTARY | 23.75MG;95MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2015-01-07 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N203312-002 | RYTARY | 36.25MG;145MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2015-01-07 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N203312-003 | RYTARY | 48.75MG;195MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2015-01-07 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N203312-004 | RYTARY | 61.25MG;245MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2015-01-07 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N203312-001 | RYTARY | 23.75MG;95MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2015-01-07 | 87673890dc5c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N203312-002 | RYTARY | 36.25MG;145MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2015-01-07 | 87673890dc5c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N203312-003 | RYTARY | 48.75MG;195MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2015-01-07 | 87673890dc5c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N203312-004 | RYTARY | 61.25MG;245MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2015-01-07 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N203312-001 | RYTARY | 23.75MG;95MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2015-01-07 | 5aa47cf7b7d7… | |
| 2021-03-12 10:30 UTC | 2021-03 | N203312-002 | RYTARY | 36.25MG;145MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2015-01-07 | 5aa47cf7b7d7… | |
| 2021-03-12 10:30 UTC | 2021-03 | N203312-003 | RYTARY | 48.75MG;195MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2015-01-07 | 5aa47cf7b7d7… | |
| 2021-03-12 10:30 UTC | 2021-03 | N203312-004 | RYTARY | 61.25MG;245MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2015-01-07 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N203312-001 | RYTARY | 23.75MG;95MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2015-01-07 | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N203312-002 | RYTARY | 36.25MG;145MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2015-01-07 | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N203312-003 | RYTARY | 48.75MG;195MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2015-01-07 | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N203312-004 | RYTARY | 61.25MG;245MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2015-01-07 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N203312-001 | RYTARY | 23.75MG;95MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2015-01-07 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N203312-002 | RYTARY | 36.25MG;145MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2015-01-07 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N203312-003 | RYTARY | 48.75MG;195MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2015-01-07 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N203312-004 | RYTARY | 61.25MG;245MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2015-01-07 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N203312-001 | RYTARY | 23.75MG;95MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2015-01-07 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N203312-002 | RYTARY | 36.25MG;145MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2015-01-07 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N203312-003 | RYTARY | 48.75MG;195MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2015-01-07 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N203312-004 | RYTARY | 61.25MG;245MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2015-01-07 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N203312-001 | RYTARY | 23.75MG;95MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2015-01-07 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N203312-002 | RYTARY | 36.25MG;145MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2015-01-07 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N203312-003 | RYTARY | 48.75MG;195MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2015-01-07 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N203312-004 | RYTARY | 61.25MG;245MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2015-01-07 | b00525d2431f… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N203312-001 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-002 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-003 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-004 | AB | 1 | d4dbc9d85df4… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N203312-001 | 8377474 | 2028-12-26 | U-219 | Drug product | 2015-01-27 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-001 | 8377474 | 2028-12-26 | U-1645 | Drug product | 2015-01-27 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-001 | 8454998 | 2028-12-26 | U-1645 | Drug product | 2015-01-27 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-001 | 8454998 | 2028-12-26 | U-1649 | Drug product | 2015-01-27 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-001 | 8454998 | 2028-12-26 | U-1646 | Drug product | 2015-01-27 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-001 | 8454998 | 2028-12-26 | U-1647 | Drug product | 2015-01-27 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-001 | 8454998 | 2028-12-26 | U-219 | Drug product | 2015-01-27 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-001 | 8557283 | 2028-12-26 | U-219 | Drug product | 2015-01-27 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-001 | 8557283 | 2028-12-26 | U-1645 | Drug product | 2015-01-27 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-001 | 9089607 | 2028-12-26 | U-1645 | Drug product | 2015-08-10 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-001 | 9089607 | 2028-12-26 | U-1720 | Drug product | 2015-08-10 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-001 | 9089608 | 2028-12-26 | Drug product | 2015-08-10 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N203312-001 | 9463246 | 2028-12-26 | U-219 | Drug product | 2016-10-12 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-001 | 9533046 | 2028-12-26 | U-219 | Drug product | 2017-01-11 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-001 | 9901640 | 2028-12-26 | U-219 | Drug product | 2018-02-28 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-002 | 8377474 | 2028-12-26 | U-219 | Drug product | 2015-01-27 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-002 | 8377474 | 2028-12-26 | U-1645 | Drug product | 2015-01-27 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-002 | 8454998 | 2028-12-26 | U-1649 | Drug product | 2015-01-27 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-002 | 8454998 | 2028-12-26 | U-219 | Drug product | 2015-01-27 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-002 | 8454998 | 2028-12-26 | U-1647 | Drug product | 2015-01-27 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-002 | 8454998 | 2028-12-26 | U-1645 | Drug product | 2015-01-27 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-002 | 8454998 | 2028-12-26 | U-1646 | Drug product | 2015-01-27 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-002 | 8557283 | 2028-12-26 | U-219 | Drug product | 2015-01-27 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-002 | 8557283 | 2028-12-26 | U-1645 | Drug product | 2015-01-27 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-002 | 9089607 | 2028-12-26 | U-1645 | Drug product | 2015-08-10 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-002 | 9089607 | 2028-12-26 | U-1720 | Drug product | 2015-08-10 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-002 | 9089608 | 2028-12-26 | Drug product | 2015-08-10 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N203312-002 | 9463246 | 2028-12-26 | U-219 | Drug product | 2016-10-12 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-002 | 9533046 | 2028-12-26 | U-219 | Drug product | 2017-01-11 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-002 | 9901640 | 2028-12-26 | U-219 | Drug product | 2018-02-28 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-003 | 8377474 | 2028-12-26 | U-219 | Drug product | 2015-01-27 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-003 | 8377474 | 2028-12-26 | U-1645 | Drug product | 2015-01-27 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-003 | 8454998 | 2028-12-26 | U-1645 | Drug product | 2015-01-27 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-003 | 8454998 | 2028-12-26 | U-1647 | Drug product | 2015-01-27 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-003 | 8454998 | 2028-12-26 | U-1649 | Drug product | 2015-01-27 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-003 | 8454998 | 2028-12-26 | U-219 | Drug product | 2015-01-27 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-003 | 8454998 | 2028-12-26 | U-1646 | Drug product | 2015-01-27 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-003 | 8557283 | 2028-12-26 | U-1645 | Drug product | 2015-01-27 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-003 | 8557283 | 2028-12-26 | U-219 | Drug product | 2015-01-27 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N203312-003 | 9089607 | 2028-12-26 | U-1645 | Drug product | 2015-08-10 | d4dbc9d85df4… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | REMEDYREPACK INC. | 4ce99f65-5857-448c-b22a-9b3b64de69e2 | 2026-04-29 | Warnings, Adverse reactions | 203312 NDA203312 |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | REMEDYREPACK INC. | b29e58f0-67b1-4036-a4a8-4915a8c13cdf | 2026-04-24 | Warnings, Adverse reactions | 203312 NDA203312 |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | REMEDYREPACK INC. | beedd327-bbc5-4f17-838a-4e72bf0867f0 | 2026-04-24 | Warnings, Adverse reactions | 203312 NDA203312 |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | REMEDYREPACK INC. | 9ac804f1-7e15-48bc-8ae9-25181a629dd4 | 2026-04-24 | Warnings, Adverse reactions | 203312 NDA203312 |
| RYTARY | CARBIDOPA AND LEVODOPA | Amneal Pharmaceuticals LLC | 6c1f7cd4-de56-45c1-a734-5e77b4aeb6f7 | 2026-03-26 | Warnings, Adverse reactions | 203312 NDA203312 64896-661 64896-662 64896-663 64896-664 |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Zydus Pharmaceuticals USA Inc. | 74e7f96b-de31-4e3c-b32d-11421b291d4e | 2025-11-14 | Warnings, Adverse reactions | 203312 NDA203312 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 64896-661 | RYTARY | Levodopa and Carbidopa | Amneal Pharmaceuticals LLC | NDA | Current |
| 64896-661 | RYTARY | Levodopa and Carbidopa | Amneal Pharmaceuticals LLC | NDA | Current |
| 64896-661 | RYTARY | Levodopa and Carbidopa | Amneal Pharmaceuticals LLC | NDA | Current |
| 64896-661 | RYTARY | Levodopa and Carbidopa | Amneal Pharmaceuticals LLC | NDA | Current |
| 64896-661 | RYTARY | Levodopa and Carbidopa | Impax Specialty Pharma | NDA | Current |
| 64896-662 | RYTARY | Levodopa and Carbidopa | Amneal Pharmaceuticals LLC | NDA | Current |
| 64896-662 | RYTARY | Levodopa and Carbidopa | Amneal Pharmaceuticals LLC | NDA | Current |
| 64896-662 | RYTARY | Levodopa and Carbidopa | Amneal Pharmaceuticals LLC | NDA | Current |
| 64896-662 | RYTARY | Levodopa and Carbidopa | Amneal Pharmaceuticals LLC | NDA | Current |
| 64896-662 | RYTARY | Levodopa and Carbidopa | Impax Specialty Pharma | NDA | Current |
| 64896-663 | RYTARY | Levodopa and Carbidopa | Amneal Pharmaceuticals LLC | NDA | Current |
| 64896-663 | RYTARY | Levodopa and Carbidopa | Amneal Pharmaceuticals LLC | NDA | Current |
| 64896-663 | RYTARY | Levodopa and Carbidopa | Amneal Pharmaceuticals LLC | NDA | Current |
| 64896-663 | RYTARY | Levodopa and Carbidopa | Amneal Pharmaceuticals LLC | NDA | Current |
| 64896-663 | RYTARY | Levodopa and Carbidopa | Impax Specialty Pharma | NDA | Current |
| 64896-664 | RYTARY | Levodopa and Carbidopa | Amneal Pharmaceuticals LLC | NDA | Current |
| 64896-664 | RYTARY | Levodopa and Carbidopa | Amneal Pharmaceuticals LLC | NDA | Current |
| 64896-664 | RYTARY | Levodopa and Carbidopa | Amneal Pharmaceuticals LLC | NDA | Current |
| 64896-664 | RYTARY | Levodopa and Carbidopa | Amneal Pharmaceuticals LLC | NDA | Current |
| 64896-664 | RYTARY | Levodopa and Carbidopa | Impax Specialty Pharma | NDA | Current |